BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer

Prognostic Relevance of c-MycandBMI1Expression in Patients With Glioblastoma

(2012) Tonia Cenci et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences

(2012) Hifzur Rahman Siddique et al.   STEM CELLS

Novel diagnostic biomarkers for prostate cancer

(2012) Chikezie O. Madu et al.   Journal of Cancer

Tumor markers in prostate cancer I: Blood-based markers

(2011) Shahrokh F. Shariat et al.   ACTA ONCOLOGICA

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

(2011) Hifzur Rahman Siddique et al.   CLINICAL CANCER RESEARCH

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

(2011) Andrew J. Armstrong et al.   EUROPEAN UROLOGY

Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model

(2011) Hifzur Rahman Siddique et al.   INTERNATIONAL JOURNAL OF CANCER

Management of Rising Prostate-specific Antigen After a Negative Biopsy

(2011) David A. Levy et al.   Current Urology Reports

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen

(2009) Yves Fradet   CURRENT OPINION IN UROLOGY